hiv lfn-p24
Vaccineexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 2, 1999 (NCT00000946)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hiv lfn-p24
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00412477 | Phase 1 | Aug 20, 2004 | United States Army |
| NCT00000946 | Phase 1 | Nov 2, 1999 | National Institute of Allergy and Infectious Diseases (NIAID), University of Alabama, Birmingham |
| NCT00002204 | Phase 1 | Nov 2, 1999 | Chiron |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chiron | For profit | 1 | 1 | 1 | 1999 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 1999 |
| United States Army | Government | 1 | 1 | 1 | 2004 |
| University of Alabama, Birmingham | Academic/Hospital | 1 | 0 | 1 | 1999 |
4 organizations
Page 1 / 1